ATLANTA—Georgia State University has received a five-year, $2.2 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to develop combination therapies for respiratory syncytial virus, or RSV, and related respiratory viruses, which are top causes of infant hospitalization in the U.S.
Archives for August 2018
ATLANTA—A new, double-layered nanoparticle vaccine made with peptides has been found to effectively protect mice against influenza A virus, according to a study led by Georgia State University.
ATLANTA—A gene from the deadly Ebola virus that allows the virus to escape from the human immune system has been identified in the genome of a group of bats that is found worldwide, including North America. The gene appears to have been stolen from the virus by the bats and adapted to regulate their own immune response, according to a recent study led by Georgia State University.